• Facebook
  • Twitter
  • Linkedin
Oslo Cancer Cluster - Innovation Park
  • About
    • A power centre
    • Board
    • Construction stage 2
  • Companies
  • News
  • Events
  • Property
    • Property Overview
    • The building
    • Leasing
    • Services
    • Floor plans
    • Technical solutions
    • Illustrations
  • Contact
  • Menu
You are here: Home / Exciting cross-Atlantic collaboration on Individualized Cancer Patient Care / Members / Exciting cross-Atlantic collaboration on Individualized Cancer Patient...

Exciting cross-Atlantic collaboration on Individualized Cancer Patient Care

August 16, 2016/in Members, News, Oslo Cancer Cluster, Personalized Cancer Medicine /by oslocancer

Oslo Cancer Cluster member the Cancer Registry of Norway and the US Lawrence Livermore National Laboratory (LLNL)

Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on Google+
  • Share on Linkedin
  • Share by Mail

Oslo Cancer Cluster - blue
Oslo Cancer Cluster

OCC Innovation Park - orange
Oslo Cancer Cluster Innovation Park

OCC Incubator - green
Oslo Cancer Cluster Incubator

External - gray
External

 

CONTACT

Oslo Cancer Cluster Innovation Park
Ullernchauséen 64/66
0379 Oslo
Norway

Contact us >

Info

Oslo Cancer Cluster Innovation Park opened in May 2015.

The Innovation Park brings together the oncology-value chain from basic research to industry within the Oslo-area.

Our vision is to create Europe's leading environment for education, research and industry within oncology, shortening the development time of new cancer treatments.

About

  • A power centre
  • Board
  • Construction stage 2
To OCC
To Oslo Cancer Cluster Incubator
© Copyright - Oslo Cancer Cluster - Innovation Park - Organization number: 991068503 - Design by Fete Typer - Privacy notice and cookies
PCI Biotech with positive opinion for Orphan Drug Designation Photocure with exciting news: FDA-approval of new packaging for bladder cancer...
Scroll to top